Cite
HARVARD Citation
McKeen, J. et al. (2016). Acyclovir versus Valganciclovir for Preventing Cytomegalovirus Infection in Intermediate-Risk Liver Transplant Recipients. Progress in transplantation. pp. 39-44. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
McKeen, J. et al. (2016). Acyclovir versus Valganciclovir for Preventing Cytomegalovirus Infection in Intermediate-Risk Liver Transplant Recipients. Progress in transplantation. pp. 39-44. [Online].